HARBOURVEST PARTNERS LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$343,000
-14.9%
79,1930.0%0.04%
+15.8%
Q3 2021$403,000
-19.6%
79,1930.0%0.04%
-20.8%
Q2 2021$501,000
-18.1%
79,1930.0%0.05%
-41.5%
Q1 2021$612,000
+17.9%
79,1930.0%0.08%
-59.6%
Q4 2020$519,000
-1.5%
79,1930.0%0.20%
+4.1%
Q3 2020$527,000
-20.2%
79,1930.0%0.20%
-31.3%
Q2 2020$660,000
+8.7%
79,1930.0%0.28%
-3.1%
Q1 2020$607,000
-7.8%
79,1930.0%0.29%
+8.1%
Q4 2019$658,000
+12.7%
79,1930.0%0.27%
+11.5%
Q3 2019$584,000
-67.2%
79,193
-50.0%
0.24%
-27.0%
Q2 2019$1,778,000
+108.9%
158,386
+100.0%
0.33%
+10.6%
Q1 2019$851,000
-28.8%
79,1930.0%0.30%
-46.9%
Q4 2018$1,196,000
-16.4%
79,1930.0%0.57%
-56.1%
Q3 2018$1,430,000
-21.0%
79,1930.0%1.29%
-43.4%
Q2 2018$1,810,000
+197.7%
79,193
+102.0%
2.29%
+772.5%
Q2 2017$608,000
+40.7%
39,199
+56.8%
0.26%
+8.3%
Q1 2017$432,000
+96.4%
25,000
+25.0%
0.24%
+261.2%
Q4 2016$220,000
+115.7%
20,000
+100.0%
0.07%
+36.7%
Q2 2016$102,00010,0000.05%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders